Email ID
Password
Scrip   
Cornerstone receives US court approval to acquire Factive
04 September 2009
Simon Varcoe

Cornerstone Therapeutics has received approval from a US bankruptcy court to acquire certain commercial rights to the antibiotic Factive (gemifloxacin mesylate) from Oscient Pharmaceuticals, which filed for bankruptcy protection in July.

The US-based speciality pharmaceutical company received...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36